These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 3512613)

  • 41. Cyclosporine-associated glomerular and arteriolar thrombosis following renal transplantation.
    First MR; Smith RD; Weiss MA; Schroeder TJ; Kant KS; Munda R; Stephens GW; Penn I; Alexander JW
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1567-70. PubMed ID: 2652509
    [No Abstract]   [Full Text] [Related]  

  • 42. Monitoring of renal allografts by Doppler ultrasound.
    Ubhi CS; Irving HC; Norwood HM; Guillou PJ; Giles GR
    Ann R Coll Surg Engl; 1987 Sep; 69(5):229-32. PubMed ID: 3314635
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fine-needle intrarenal manometry: a new test for rejection in cyclosporin-treated recipients of kidney transplants.
    Salaman JR; Griffin PJ
    Lancet; 1983 Sep; 2(8352):709-11. PubMed ID: 6136842
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Differential diagnosis of the rejection crisis and toxic and immune-induced nephropathy].
    Belorusov OS; Goriaĭnov VA; Chemisova GG; Morozova MM
    Khirurgiia (Mosk); 1989 Jul; (7):96-102. PubMed ID: 2796204
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Borderline Changes on Dysfunctional Renal Allograft Biopsies: Clinical Relevance in a Living Related Renal Transplant Setting.
    Mubarak M; Shakeel S; Abbas K; Aziz T; Zafar MN; Naqvi SA; Rizvi SA
    Exp Clin Transplant; 2017 Feb; 15(Suppl 1):24-27. PubMed ID: 28260426
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nature and mediators of renal lesions in kidney transplant patients given cyclosporine for more than one year.
    Benigni A; Bruzzi I; Mister M; Azzollini N; Gaspari F; Perico N; Gotti E; Bertani T; Remuzzi G
    Kidney Int; 1999 Feb; 55(2):674-85. PubMed ID: 9987092
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Histologic findings in protocol biopsies of transplanted kidneys].
    Tichý T; Tichý M; Zadrazil J; Krejcí K; Horcicka V; al-Jabry S; Bachleda P; Král V; Dusek J
    Cesk Patol; 2003 Jan; 39(1):11-6. PubMed ID: 12673937
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cyclosporine nephrotoxicity and the consequences of conversion to azathioprine.
    Chapman JR; Morris PJ
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):254-60. PubMed ID: 3895664
    [No Abstract]   [Full Text] [Related]  

  • 49. [Rejection nephropathy before and after therapeutic administration of cyclosporin A].
    Rossmann P; Jirka J; Zástava V; Reneltová I; Kocandrle V
    Zentralbl Allg Pathol; 1986; 132(5-6):435-58. PubMed ID: 3551395
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Acute rejection episodes after renal transplantation in children under cyclosporin A treatment.
    Hoyer PF; Offner G; Krohn HP; Brodehl J
    Pediatr Nephrol; 1987 Jul; 1(3):253-9. PubMed ID: 3153285
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Renography and biopsy-verified acute rejection in renal allotransplanted patients receiving cyclosporin A.
    Thomsen HS; Nielsen SL; Larsen S; Løkkegaard H
    Eur J Nucl Med; 1987; 12(10):473-6. PubMed ID: 3552684
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Is arteriolar vacuolization a predictor of calcineurin inhibitor nephrotoxicity?
    Horike K; Takeda A; Yamaguchi Y; Ogiyama Y; Yamauchi Y; Murata M; Kawaguchi T; Suzuki T; Otsuka Y; Inaguma D; Goto N; Watarai Y; Uchida K; Morozumi K
    Clin Transplant; 2011 Jul; 25 Suppl 23():23-7. PubMed ID: 21623910
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Differential expression of tissue factor (TF) in calcineurin inhibitor-induced nephrotoxicity and rejection--implications for development of a possible diagnostic marker.
    Osterholm C; Veress B; Simanaitis M; Hedner U; Ekberg H
    Transpl Immunol; 2005 Dec; 15(2):165-72. PubMed ID: 16412961
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sonography in the diagnosis of acute renal allograft rejection and cyclosporine nephrotoxicity.
    Linkowski GD; Warvariv V; Filly RA; Vincenti F
    AJR Am J Roentgenol; 1987 Feb; 148(2):291-5. PubMed ID: 3541547
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cyclosporin A in renal transplantation: a prospective randomized trial.
    Ferguson RM; Rynasiewicz JJ; Sutherland DE; Simmons RL; Najarian JS
    Surgery; 1982 Aug; 92(2):175-82. PubMed ID: 6285533
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mononuclear cells in acute allograft glomerulopathy.
    Tuazon TV; Schneeberger EE; Bhan AK; McCluskey RT; Cosimi AB; Schooley RT; Rubin RH; Colvin RB
    Am J Pathol; 1987 Oct; 129(1):119-32. PubMed ID: 2821814
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Diagnosis of renal allograft rejection by macrophage immunostaining with a CD14 monoclonal antibody, WT14.
    Bogman MJ; Dooper IM; van de Winkel JG; Tax WJ; Hoitsma AJ; Assmann KJ; Ruiter DJ; Koene RA
    Lancet; 1989 Jul; 2(8657):235-8. PubMed ID: 2474119
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The use of fine-needle intrarenal manometry in the management of renal transplant patients receiving cyclosporine.
    Salaman JR; Griffin PJ
    Transplantation; 1985 May; 39(5):523-6. PubMed ID: 3887693
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cyclosporin-A deposits in renal allografts.
    von Willebrand E; Häyry P
    Lancet; 1983 Jul; 2(8343):189-92. PubMed ID: 6135029
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Amplification of the nephrotoxic effect of cyclosporine by preexistent chronic histological lesions in the kidney.
    Leunissen KM; Bosman FT; Nieman FH; Kootstra G; Vromen MA; Noordzij TC; van Hooff JP
    Transplantation; 1989 Oct; 48(4):590-3. PubMed ID: 2799911
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.